- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 5, 2025 | 3.1M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 1.5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 831.04K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 230.61K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 151.19K sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$4.34M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$3.8M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $2.73M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $2.71M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $4.19M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $2.87M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $3.64M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $4.69M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $6.14M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $4.71M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $1.95M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $420.42K |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $644.19K |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $550.92K |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $669.25K |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $604.01K |
| Current Assets | Q3 2025 · Sep 30, 2025 | $2.84M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.76M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $4.86M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $5.3M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.59 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$6.86 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$8.45 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$42.73 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.59 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$6.86 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$8.45 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$42.73 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $698.94K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.06M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $881.44K |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $2.83M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $317.63K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $950.74K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $233.09K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $558.18K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$2.38M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$5.7M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$1.57M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$1.75M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$1.95M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$6.46M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$2.3M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$2.21M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$2.38M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$5.7M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$1.95M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$5.66M |
| Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Revenue | Q3 2025 · Sep 30, 2025 | $0 |
| Revenue | Q3 2025 · Sep 30, 2024 | $0 |
| Revenue | Q3 2025 · Sep 30, 2024 | $0 |